Recent health updates include Texas experiencing a lull in measles cases, Omada’s successful Nasdaq debut, no bird flu ...

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

Science Natural Supplements Berberine Sets New Standard for Weight Loss, Blood Sugar, and Gut Health Support NEW YORK CITY, ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

When career coach Shoshanna Davis asked TikTok to share the “most unhinged” things they’ve done to land a job — social media ...